Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4041048)

Published in BMC Cancer on May 24, 2014

Authors

Mark Whitehead, Peter Ohlschläger, Fahad N Almajhdi, Leonor Alloza, Pablo Marzábal, Ann E Meyers, Inga I Hitzeroth1, Edward P Rybicki

Author Affiliations

1: Department of Molecular and Cell Biology, University of Cape Town, Private Bag X3, Cape Town, Rondebosch 7700, South Africa. Inga.Hitzeroth@uct.ac.za.

Articles cited by this

Retracted An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J (2003) 9.35

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol (1989) 8.68

Chapter 1: HPV in the etiology of human cancer. Vaccine (2006) 6.61

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med (1985) 3.86

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol (1993) 3.73

The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci (1992) 1.68

Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood (2011) 1.68

Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus. FEBS Lett (2002) 1.66

Clinical applications of DNA vaccines: current progress. Clin Infect Dis (2011) 1.65

Plant-based production of biopharmaceuticals. Curr Opin Plant Biol (2004) 1.60

Two Structural Domains Mediate Two Sequential Events in [gamma]-Zein Targeting: Protein Endoplasmic Reticulum Retention and Protein Body Formation. Plant Cell (1994) 1.47

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. Hum Vaccin (2011) 1.46

Plant-made vaccines for humans and animals. Plant Biotechnol J (2010) 1.44

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine (1998) 1.40

Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol (1994) 1.30

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol (2007) 1.25

Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin Biol Ther (2008) 1.24

Towards molecular farming in the future: transient protein expression in plants. Biotechnol Appl Biochem (1999) 1.18

Human papillomavirus vaccines for cervical cancer. Curr Opin Immunol (1996) 1.16

The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice. Gene Ther (2001) 1.11

Eukaryotic protein production in designed storage organelles. BMC Biol (2009) 1.11

An E7-based therapeutic vaccine protects mice against HPV16 associated cancer. Vaccine (2009) 1.06

Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur J Immunol (1997) 1.00

Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine (2007) 0.99

Protein body induction: a new tool to produce and recover recombinant proteins in plants. Methods Mol Biol (2009) 0.97

Emerging human papillomavirus vaccines. Expert Opin Emerg Drugs (2012) 0.96

Role of structural domains for maize gamma-zein retention in Xenopus oocytes. Planta (1994) 0.95

Cervical cancer vaccines: recent advances in HPV research. Viral Immunol (2003) 0.95

An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Vaccine (2006) 0.90

CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. Cancer Res (2003) 0.87

Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study. Clin Vaccine Immunol (2006) 0.87

A review of human papillomavirus vaccines: from basic science to clinical trials. Front Biosci (2003) 0.84

Vaccination strategies for the treatment and prevention of cervical cancer. Curr Opin Oncol (2004) 0.81

Articles by these authors

Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 2.18

The evolutionary value of recombination is constrained by genome modularity. PLoS Genet (2005) 1.26

A proposal to change existing virus species names to non-Latinized binomials. Arch Virol (2010) 1.18

Recombination, decreased host specificity and increased mobility may have driven the emergence of maize streak virus as an agricultural pathogen. J Gen Virol (2008) 1.12

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. J Virol (2003) 1.11

Evidence of unique genotypes of beak and feather disease virus in southern Africa. J Virol (2004) 1.06

Insights into the role and function of L2, the minor capsid protein of papillomaviruses. Arch Virol (2009) 1.05

A protocol for the rapid isolation of full geminivirus genomes from dried plant tissue. J Virol Methods (2008) 1.05

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis (2006) 1.03

Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol (2008) 1.02

Evidence of ancient papillomavirus recombination. J Gen Virol (2006) 1.01

High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J (2009) 1.00

Rapid host adaptation by extensive recombination. J Gen Virol (2009) 1.00

A three-nucleotide mutation altering the Maize streak virus Rep pRBR-interaction motif reduces symptom severity in maize and partially reverts at high frequency without restoring pRBR-Rep binding. J Gen Virol (2005) 0.99

Genetic analysis of maize streak virus isolates from Uganda reveals widespread distribution of a recombinant variant. J Gen Virol (2007) 0.98

Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology (2006) 0.98

Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. Virus Res (2006) 0.97

Experimental evidence indicating that mastreviruses probably did not co-diverge with their hosts. Virol J (2009) 0.97

Experimental observations of rapid Maize streak virus evolution reveal a strand-specific nucleotide substitution bias. Virol J (2008) 0.96

A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J (2013) 0.96

Restoration of native folding of single-stranded DNA sequences through reverse mutations: an indication of a new epigenetic mechanism. Arch Biochem Biophys (2006) 0.95

A prime-boost immunisation regimen using recombinant BCG and Pr55(gag) virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons. Vaccine (2009) 0.94

Human papillomavirus vaccines in plants. Expert Rev Vaccines (2010) 0.93

Reconstructing the history of maize streak virus strain a dispersal to reveal diversification hot spots and its origin in southern Africa. J Virol (2011) 0.93

The use of transient expression systems for the rapid production of virus-like particles in plants. Curr Pharm Des (2013) 0.92

Effect of gamma radiation and accelerated aging on the mechanical and thermal behavior of HDPE/HA nano-composites for bone tissue regeneration. Biomed Eng Online (2013) 0.90

Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice. J Gen Virol (2004) 0.89

Dating the origins of the maize-adapted strain of maize streak virus, MSV-A. J Gen Virol (2009) 0.89

Green fluorescent protein reporter system with transcriptional sequence heterogeneity for monitoring the interferon response. J Virol (2011) 0.88

Maize streak virus-resistant transgenic maize: a first for Africa. Plant Biotechnol J (2007) 0.88

Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients. J Med Virol (2012) 0.88

Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. Virus Res (2008) 0.88

Development of a SYBR Green I based real-time RT-PCR assay for detection and quantification of bovine coronavirus. Mol Cell Probes (2011) 0.87

Maize streak virus: an old and complex 'emerging' pathogen. Mol Plant Pathol (2010) 0.87

Setting up a platform for plant-based influenza virus vaccine production in South Africa. BMC Biotechnol (2012) 0.86

Global genetic diversity and geographical and host-species distribution of beak and feather disease virus isolates. J Gen Virol (2010) 0.86

A deletion and point mutation study of the human papillomavirus type 16 major capsid gene. Virus Res (2006) 0.86

Viable chimaeric viruses confirm the biological importance of sequence specific maize streak virus movement protein and coat protein interactions. Virol J (2008) 0.86

Immunogenicity of an HPV-16 L2 DNA vaccine. Vaccine (2009) 0.86

A highly divergent South African geminivirus species illuminates the ancient evolutionary history of this family. Virol J (2009) 0.86

Diversity of dicotyledenous-infecting geminiviruses and their associated DNA molecules in southern Africa, including the South-west Indian ocean islands. Viruses (2012) 0.85

Replicative intermediates of maize streak virus found during leaf development. J Gen Virol (2009) 0.85

Virus-like particles produced in plants as potential vaccines. Expert Rev Vaccines (2013) 0.85

HIV-1 subtype C Pr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine. J Gen Virol (2008) 0.85

Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system. Biotechnol Prog (2009) 0.85

Vaccination strategies for the prevention of cervical cancer. Expert Rev Anticancer Ther (2005) 0.84

Identification of long intergenic region sequences involved in maize streak virus replication. J Gen Virol (2007) 0.84

T cell response to human papillomavirus 16 E7 in mice: comparison of Cr release assay, intracellular IFN-gamma production, ELISPOT and tetramer staining. Intervirology (2002) 0.84

Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. Plant Biotechnol J (2013) 0.84

The capsid protein of beak and feather disease virus binds to the viral DNA and is responsible for transporting the replication-associated protein into the nucleus. J Virol (2006) 0.84

Techno-economic analysis of horseradish peroxidase production using a transient expression system in Nicotiana benthamiana. Appl Biochem Biotechnol (2014) 0.83

Comparative analysis of Panicum streak virus and Maize streak virus diversity, recombination patterns and phylogeography. Virol J (2009) 0.83

Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model. J Virol (2013) 0.83

Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice. Vaccine (2005) 0.83

Recombination hotspots and host susceptibility modulate the adaptive value of recombination during maize streak virus evolution. BMC Evol Biol (2011) 0.82

Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7. Int J Cancer (2011) 0.82

A rep-based hairpin inhibits replication of diverse maize streak virus isolates in a transient assay. J Gen Virol (2011) 0.82

Development of human papillomavirus chimaeric L1/L2 candidate vaccines. Arch Virol (2013) 0.81

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. BMC Biotechnol (2007) 0.81

Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A. Virol J (2011) 0.80

Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media. Virol J (2012) 0.80

An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma. Mol Ther (2011) 0.80

Beak and feather disease viruses circulating in Cape parrots (Poicepahlus robustus) in South Africa. Arch Virol (2014) 0.79

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas. Virol J (2008) 0.79

The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine. Virol J (2011) 0.79

An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins. Arch Virol (2008) 0.79

BIP co-chaperone MTJ1/ERDJ1 interacts with inter-alpha-trypsin inhibitor heavy chain 4. Biochem Biophys Res Commun (2005) 0.79

Inhibition of maize streak virus (MSV) replication by transient and transgenic expression of MSV replication-associated protein mutants. J Gen Virol (2007) 0.79

Replication modes of Maize streak virus mutants lacking RepA or the RepA-pRBR interaction motif. Virology (2013) 0.78

Hemagglutinin and neuraminidase genes of influenza B viruses circulating in Riyadh, Saudi Arabia during 2010-2011: evolution and sequence analysis. J Med Virol (2013) 0.78

Adaptive evolution by recombination is not associated with increased mutation rates in Maize streak virus. BMC Evol Biol (2012) 0.78

Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production. BMC Biotechnol (2010) 0.78

A new African streak virus species from Nigeria. Arch Virol (2008) 0.78

Expression in tobacco and purification of beak and feather disease virus capsid protein fused to elastin-like polypeptides. J Virol Methods (2013) 0.78

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs. Virol J (2011) 0.77

A unique isolate of beak and feather disease virus isolated from budgerigars (Melopsittacus undulatus) in South Africa. Arch Virol (2010) 0.76

Plant made anti-HIV microbicides--a field of opportunity. Biotechnol Adv (2012) 0.76

HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice. J Immune Based Ther Vaccines (2010) 0.76

Single-walled carbon nanotubes induce cytotoxicity and DNA damage via reactive oxygen species in human hepatocarcinoma cells. In Vitro Cell Dev Biol Anim (2014) 0.75

Beak and feather disease virus: correlation between viral load and clinical signs in wild Cape parrots (Poicepahlus robustus) in South Africa. Arch Virol (2014) 0.75

Characterization of H5N1 influenza A virus that caused the first highly pathogenic avian influenza outbreak in Saudi Arabia. J Infect Dev Ctries (2015) 0.75

The influence of the extensional viscosity of very low concentrations of high molecular mass water-soluble polymers on atomisation and droplet impact. Pest Manag Sci (2008) 0.75